Home › NDC Lookup › Ingredients › Bacitracin › 00536-1256-28
Bacitracin 500 U/g Ointment, 30 g — NDC 00536-1256-28 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Bacitracin 500 U/g Ointment, 30 g — NDC 0536-1256-28 (Billing 00536-1256-28)

by RUGBY LABORATORIES · 30 g in 1 BOX

This is a package of 30 g of Bacitracin 500 U/g Ointment from RUGBY LABORATORIES, marketed since Apr 2020 and currently FDA-listed; retail pharmacies pay about $0.0551 per g (NADAC). It is this product's only package size.

NDC 00536-1256-28
🏷️ FDA NDC (as labeled) 0536-1256-28 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0536-1256-28 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1256 product · 28 package
Package marketed since
Apr 30, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
30 g per package
Barcode (UPC)
0305361256289
Medicaid fills, this package
19,016 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1256-28
Product NDC 0536-1256
11-digit billing NDC 00536125628
NCPDP billing unit GM — per gram (weight)
RxCUI 1648110
UNII 58H6RWO52I
UPC 0305361256289
Application # M004
SPL Set ID aa9f414e-d8de-417d-9ccd-027d5a5f5499
Physiologic effect Decreased Cell Wall Synthesis & Repair
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-04-30
Route TOPICAL
Dosage form OINTMENT
Substance BACITRACIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90100010004210
GPI class Bacitracin
GCN Seq No 007731
GCN 31812
HICL code 004047
Ingredient (HICL) Bacitracin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5W
Therapeutic class — specific (HIC3) Topical Antibiotics
AHFS code 84:04.04.00
AHFS class Antibacterials (84:04)
FDB label name BACITRACIN 500 UNIT/GM OINTMNT
FDB brand name Bacitracin
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007731
  • GCN: 31812
  • GPI-14 (Medi-Span): 90100010004210
  • HICL (First Databank): 004047
  • AHFS class code: 84:04.04.00
  • RxCUI (RxNorm): 1648110
Why two NDCs? The FDA registers this code as 0536-1256-28 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1256-28. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antibiotics for topical use class.

Drug family (ATC) Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BACITRACIN 500 UNIT/GM OINTMNT Ingredient Bacitracin
📖 What it is MedlinePlus · NLM

Bacitracin is used to help prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Bacitracin is in a class of medications called antibiotics. Bacitracin works by stopping the growth of bacteria.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It is first aid to help prevent infection in minor cuts, scrapes, and burns. One cream product also has directions for athlete's foot, ringworm and jock itch.
  • Clean the area, then put on a small amount, about the size of your fingertip. Do this 1 to 3 times a day, and you can cover it with a sterile bandage. One cream product is used as...
  • Not longer than 1 week unless a doctor tells you to. If the problem is not getting better or gets worse, stop and check with a doctor.
  • Stop if you get a rash or any allergic reaction, and talk to a doctor. Don't use it if you are allergic to any ingredient.
📖 Read our full Bacitracin Topical guide →
7
Nutrient depletion considerations

Bacitracin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.055 $1.65 / 30 g
Medicaid paysCMS SDUD · 12 mo $0.4567 $13.70 / 30 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2021 Dec 2025 Apr 2026 Sep 2026 $0.067 $0.054
▼ Down 9% over the last 14 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1256-28 You're viewing this Main listing 30 g in 1 BOX 2020-04-30 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bacitracin 500 U/gthis 00536-1256-28 RUGBY 30 g $0.055 — Availability likely —
Bacitracin 500 [USP'U]/g 00713-0280-31 Cosette 28.4 g $0.073 — Availability likely +33%
Bacitracin 500 [iU]/g 68001-0477-46 BluePoint 1 tube $0.094 — Availability likely +70%
Bacitracin 500 [USP'U]/g 45802-0060-01 Padagis 1 tube $0.117 — Availability likely +113%
Major Bacitracin 500 [USP'U]/g 00904-7402-67 Major 144 packets $0.121 — FDA listed +119%
signature care first aid antibiotic 500 [USP'U]/g 21130-0757-64 Safeway 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 30142-0536-64 Kroger 1 tube — — FDA listed —
Antibiotic 500 [USP'U]/g 36800-0536-64 Topco 1 tube — — FDA listed —
bacitracin 500 [USP'U]/g 37808-0536-64 H 1 tube — — FDA listed —
MediChoice Bacitracin 500 [iU]/g 39892-0810-01 O&M 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 41226-0880-02 Kroger 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 41250-0844-64 Meijer 1 tube — — FDA listed —
first aid antibiotic 500 [USP'U]/g 42507-0536-64 HyVee 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 50090-0815-00 A-S 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 50090-0845-00 A-S 144 packets — — FDA listed —
Rexall Antibiotic 500 [USP'U]/g 55910-0536-64 Dolgencorp, 1 tube — — FDA listed —
Publix Bacitracin Zinc 500 [USP'U]/g 56062-0815-28 PUBLIX 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 59779-0536-64 CVS 1 tube — — FDA listed —
Bacitracin 500 [iU]/g 63187-0299-01 Proficient 28.35 g — — FDA listed —
Bacitracin 500 [USP'U]/1000mg 67777-0116-10 Dynarex 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 68071-5253-03 NuCare 28.4 g — — FDA listed —
Bacitracin 500 [USP'U]/g 68788-8643-02 Preferred 28.4 g — — FDA listed —
Bacitracin 500 [USP'U]/g 68788-9794-02 Preferred 28 g — — FDA listed —
TheraCare Bacitracin Zinc 500 [USP'U]/g 71101-0019-01 Veridian 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 71205-0057-01 Proficient 28.4 g — — FDA listed —
Vitastem Ultra First Aid Antibiotic 500 U/g 71262-0013-15 Viaderma 1 bottle — — FDA listed —
Viaderma Care First Aid 500 U/g 71262-0015-15 ViaDerma 1 bottle — — FDA listed —
Bacitracin 500 [USP'U]/g 71335-2731-01 Bryant 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 72162-2280-02 Bryant 144 packets — — FDA listed —
astonea First Aid 500 [USP'U]/g 77338-0303-52 ASTONEA 9 g — — FDA listed —
Bacitracin 500 [USP'U]/g 84387-0002-01 ALLIED 28.4 g — — FDA listed —
Bacitracin 500 [iU]/g 87236-0000-01 AlderMed 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Apr 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Bacitracin Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII N6K5787QVP
    Light mineral oil is a clear, odorless liquid derived from petroleum. In medicines, it acts as a lubricant and emollient to help the product spread smoothly and improve texture.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also stateslight mineral oil, white petrolatum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRUGBY LABORATORIES
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedApr 2020
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 12 words ▾

Uses first aid to help prevent infection in: minor cuts scrapes burns

⏱️ Dosage and Administration 40 words ▾

Directions clean the affected area apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage

⚠️ Warnings 87 words ▾

Warnings For external use only. Do not use in the eyes on large areas of the body if you are allergic to any of the ingredients Ask a doctor before use if you have deep or puncture wounds animal bites serious burns Stop use and ask a doctor if you need to use longer than 1 week condition persists or gets worse rash or other allergic reaction develops Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.

🧪 Active Ingredient 12 words ▾

Active ingredients (in each gram) Bacitracin 500 units Purpose First aid antibiotic

🧪 Inactive Ingredients 7 words ▾

Inactive ingredients light mineral oil, white petrolatum

🎯 Purpose 4 words ▾

Purpose First aid antibiotic

📄 Do Not Use 21 words ▾

Do not use in the eyes on large areas of the body if you are allergic to any of the ingredients

📄 Ask a Doctor Before Use If 16 words ▾

Ask a doctor before use if you have deep or puncture wounds animal bites serious burns

📄 Stop Use and Ask a Doctor If 26 words ▾

Stop use and ask a doctor if you need to use longer than 1 week condition persists or gets worse rash or other allergic reaction develops

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-639-3803

📄 Package Label / Principal Display Panel 6 words ▾

Package Labeling: Outer Package02 Inner Package02

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
19K
Units reimbursed last 4 qtrs
627.6K
Gross reimbursed last 4 qtrs
$286.6K
Avg / prescription
$15.07
Avg / unit
$0.4567
Latest quarter Q1 2026
2.4KRx
Medicaid pays / g
$0.4567
gross reimbursed
vs
NADAC / g
$0.0551
acquisition cost
=
Spread
+$0.4016
+729% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
53% FFS 47% MCO
Fee-for-service · 10,118 Rx Managed care · 8,898 Rx
State Medicaid map
Alaska: no data reported AK Maine: 1,770 units · 127 per 100k residents ME Washington: 15,826 units · 203 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 17,340 units · 302 per 100k residents MN Wisconsin: 6,638 units · 112 per 100k residents WI Michigan: 49,087 units · 489 per 100k residents MI New York: 8,424 units · 43.0 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 4,787 units · 113 per 100k residents OR Nevada: 5,293 units · 166 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 9,474 units · 295 per 100k residents IA Illinois: 31,356 units · 250 per 100k residents IL Indiana: 34,257 units · 499 per 100k residents IN Ohio: 23,770 units · 202 per 100k residents OH Pennsylvania: 34,112 units · 263 per 100k residents PA New Jersey: 16,557 units · 178 per 100k residents NJ Massachusetts: 22,579 units · 323 per 100k residents MA California: 236,636 units · 607 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 7,552 units · 382 per 100k residents NE Missouri: no data reported MO Kentucky: 40,747 units · 900 per 100k residents KY West Virginia: 2,895 units · 164 per 100k residents WV Virginia: 6,829 units · 78.4 per 100k residents VA Maryland: 6,781 units · 110 per 100k residents MD Connecticut: no data reported CT Rhode Island: 960 units · 87.7 per 100k residents RI Arizona: 9,236 units · 124 per 100k residents AZ New Mexico: 390 units · 18.4 per 100k residents NM Kansas: 1,470 units · 50.0 per 100k residents KS Arkansas: no data reported AR Tennessee: 450 units · 6.3 per 100k residents TN North Carolina: no data reported NC South Carolina: 2,024 units · 37.7 per 100k residents SC Delaware: 1,650 units · 160 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 4,065 units · 36.9 per 100k residents GA D.C.: 3,068 units · 452 per 100k residents DC Hawaii: 3,750 units · 261 per 100k residents HI Texas: 17,816 units · 58.4 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
6.3900
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 900 /100k
2 California 607 /100k
3 Indiana 499 /100k
4 Michigan 489 /100k
5 D.C. 452 /100k
6 Nebraska 382 /100k
7 Massachusetts 323 /100k
8 Minnesota 302 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Bacitracin — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bacitracin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.9K
Claims incl. refills
44
Beneficiaries
42
Spend / beneficiary
$92.36
Spend / claim
$88.16
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.